GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » GlaxoSmithKline Consumer Nigeria PLC (NSA:GLAXOSMITH) » Definitions » Institutional Ownership

GlaxoSmithKline Consumer Nigeria (NSA:GLAXOSMITH) Institutional Ownership : 1.20% (As of Jun. 09, 2024)


View and export this data going back to 2001. Start your Free Trial

What is GlaxoSmithKline Consumer Nigeria Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, GlaxoSmithKline Consumer Nigeria's institutional ownership is 1.20%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, GlaxoSmithKline Consumer Nigeria's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, GlaxoSmithKline Consumer Nigeria's Float Percentage Of Total Shares Outstanding is 0.00%.

GlaxoSmithKline Consumer Nigeria Institutional Ownership Historical Data

The historical data trend for GlaxoSmithKline Consumer Nigeria's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GlaxoSmithKline Consumer Nigeria Institutional Ownership Chart

GlaxoSmithKline Consumer Nigeria Historical Data

The historical data trend for GlaxoSmithKline Consumer Nigeria can be seen below:

2023-04-30 2023-05-31 2023-06-30 2023-07-31 2023-08-31 2023-09-30 2023-10-31 2023-11-30 2023-12-31 2024-01-31
Institutional Ownership 1.20 1.20 1.20 1.20 1.20 1.20 1.20 1.20 1.20 1.20

GlaxoSmithKline Consumer Nigeria Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

GlaxoSmithKline Consumer Nigeria (NSA:GLAXOSMITH) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » GlaxoSmithKline Consumer Nigeria PLC (NSA:GLAXOSMITH) » Definitions » Institutional Ownership
Comparable Companies
NSA:UBNP NSA:CUSTODIAN NSA:AIIC NSA:FBP NSA:STERLINGNG NSA:MBAS NSA:WEMA NSA:FCMB NSA:JUBR NSA:NSLTECH LLY JNJ MRK ABBV XSWX:ROG LSE:AZN XSWX:NOVN PFE AMGN XPAR:SAN
Traded in Other Exchanges
N/A
Address
No. 1, Industrial Avenue, Ilupeju, P.M.B. 21218, Ikeja, GSK House, Lagos, NGA
Website
https://www.ng.gsk.com
GlaxoSmithKline Consumer Nigeria PLC is a healthcare company that researches, develops, and manufactures pharmaceutical medicines, vaccines, and consumer healthcare products. The company has two reportable segments, the Consumer Healthcare segment consisting of oral care, over-the-counter (OTC) medicines, and nutritional healthcare; and the Pharmaceuticals segment consisting of vaccines and prescription drugs. The company's product line includes panadol, Andrews liver salt, Macleans, ampiclox, Sensodyne, and others. The generates maximum revenue from the Pharmaceuticals segment.

GlaxoSmithKline Consumer Nigeria (NSA:GLAXOSMITH) Headlines

No Headlines